AI-Enhanced CAR T-Cell Design

Scientists at St. Jude developed an AI-informed approach to chimeric antigen receptor (CAR) design that enhances bi-specific CAR T-cell effectiveness. The computational method screens theoretical CAR designs and optimizes them before laboratory validation. This innovation accelerates the development of immunotherapies for cancer treatment, reducing time and costs associated with traditional trial-and-error approaches. The technology demonstrates how artificial intelligence is transforming drug discovery and personalized medicine https://www.stjude.org/media-resources/news-releases/2025-medicine-science-news.html